PRE AND POST-MITRAL VALVE AREA AND RIGHT VENTRICULAR FUNCTION OF IMMEDIATE PERCUTANEOUS TRANSVENOUS MITRAL COMMISSUROTOMY (PTMC) IN PATIENTS WITH MITRAL VALVE SYSTEM

Main Article Content

Asim Ali
Aneel Ahmed
Deepak Lal
Abdul Rahman
Zafar Iqbal
Rabel Hassan

Keywords

Mitral Valve Stenosis, Percutaneous Transvenous Mitral Commissurotomy, Mitral Valve Area, Right Ventricular Function, Echocardiography, Cardiovascular Intervention

Abstract

Objective: This study aimed to evaluate the immediate effects of Percutaneous Transvenous Mitral Commissurotomy (PTMC) on mitral valve area (MVA) and right ventricular function (RVF) in patients with severe mitral stenosis.


Methods: A quasi-experimental study was conducted at the National Institute of Cardiovascular Diseases (NICVD), Karachi, from January 1, 2023, to June 30, 2023. Forty patients aged 30-80 years with severe mitral stenosis were included. Baseline and immediate post-procedural echocardiographic measurements of MVA and RVF were recorded. Data analysis included calculating means and standard deviations for continuous variables, and frequencies and percentages for categorical variables. Paired sample t-tests were used to compare pre and post-procedural MVA and RVF, with significance set at p<0.05.


Results: The mean age of participants was 36.32 ± 12.26 years; 27.5% were male and 62.5% female. The baseline MVA increased significantly from 0.9570 ± 0.280 cm² to 1.5475 ± 0.234 cm² post-PTMC (p=0.0001). RVF improved from 17.7000 ± 3.817 mm to 18.9250 ± 3.392 mm post-PTMC (p=0.012). Stratification by age, BMI, gender, smoking status, diabetes mellitus, and hypertension showed significant improvements in MVA and RVF across all categories.


Conclusion: PTMC significantly enhances MVA and RVF immediately post-procedure in patients with severe mitral stenosis. These findings support PTMC as an effective alternative to surgical interventions, particularly for high-risk surgical patients, and highlight the importance of RVF assessment in optimizing patient outcomes. The statistical analysis confirms the robustness of these improvements. Further research with larger, multicenter studies and extended follow-up is recommended to validate these results and explore long-term impacts.

Abstract 13 | PDF Downloads 2

References

1. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, et al. 2020 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5)
2. Feldman T, Herrmann HC. Percutaneous mitral valve repair and percutaneous mitral valve annuloplasty devices. Circulation. 2018;138(23):2551-63.
3. Lung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231-43.
4. Arora R, Nair M, Kalra GS, Khalilullah M. Immediate and long-term results of balloon and surgical closed mitral valvotomy: a randomized comparative study. Am Heart J. 1993;125(4):1091-4.
5. Fawzy ME. Percutaneous mitral balloon valvotomy. Catheter Cardiovasc Interv. 2007;69(2):313-21.
6. Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol. 2011;8(3):162-72.
7. Freed LA, Benjamin EJ, Levy D, Larson MG, Evans JC, Fuller DL, et al. Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart Study. J Am Coll Cardiol. 2002;40(7):1298-304.
8. Fawzy ME, Shoukri M, Awad M, Osman A, El Shaer F, Mohamed Y, et al. Long-term clinical and echocardiographic results after successful mitral balloon valvotomy and predictors of long-term outcome. Eur Heart J. 2005;26(16):1647-52.
9. Arora R, Khalilullah M, Jain P, Guptan A, Thakur AK. Percutaneous transvenous mitral commissurotomy: immediate and long-term follow-up results. Cathet Cardiovasc Diagn. 1994;32(1):24-9.
10. Lung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231-43.
11. Iung B, Cormier B, Ducimetière P, Porte JM, Nallet O, Michel PL, et al. Functional results 5 years after successful percutaneous mitral commissurotomy in a series of 528 patients and analysis of predictive factors. J Am Coll Cardiol. 1996;27(2):407-14.
12. Feldman T, Wasserman HS, Herrmann HC, Gray W, Block PC, Whitlow P, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol. 2005;46(11):2134-40.
13. Palacios IF, Tuzcu EM, Weyman AE, Newell J, Block PC. Clinical follow-up of patients undergoing percutaneous mitral balloon valvotomy. Circulation. 1995;91(3):671-6.
14. Babic UU, Pejcic P, Popovic AD, Djurisic Z, Otasevic P, Doronjski A, et al. Percutaneous balloon valvuloplasty in adults with mitral stenosis: long-term results. J Am Coll Cardiol. 1992;19(3):387-91.
15. Pandian NG, Lee RT, Makkuni P, Khabbaz KR, Duffy SJ, Ehsan A, et al. Percutaneous mitral commissurotomy in patients with calcific mitral stenosis: immediate and short-term results. J Am Coll Cardiol. 1992;19(6):1103-9.
16. Iung B, Vahanian A, Michel PL, Cormier B, Porte JM, Frank R, et al. Immediate results of percutaneous mitral commissurotomy. Eur Heart J. 1991;12(4):468-74.

Most read articles by the same author(s)